Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127550461 | 12755046 | 1 | I | 20160819 | 20160905 | 20160916 | 20160916 | EXP | FR-PFIZER INC-2016418191 | PFIZER | 44.00 | YR | M | Y | 0.00000 | 20160916 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127550461 | 12755046 | 1 | PS | Carboplatine Hospira | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 850 MG, 1X/DAY | 850 | MG | D | 76517 | 850 | MG | QD | ||||
| 127550461 | 12755046 | 2 | SS | IFOSFAMIDE EG | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 9.96 G, 1X/DAY | 10 | G | D | 6F284H6 | 0 | 9.96 | G | QD | |||
| 127550461 | 12755046 | 3 | SS | ETOPOPHOS | ETOPOSIDE PHOSPHATE | 1 | Intravenous (not otherwise specified) | 200 MG, 1X/DAY | 600 | MG | Y | 0 | 200 | MG | QD | ||||
| 127550461 | 12755046 | 4 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 750 MG, 1X/DAY | 750 | MG | D | 0 | 750 | MG | QD | ||||
| 127550461 | 12755046 | 5 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | UNK | 0 | |||||||||||
| 127550461 | 12755046 | 6 | C | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 127550461 | 12755046 | 7 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 127550461 | 12755046 | 8 | C | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 127550461 | 12755046 | 9 | C | ACUPAN | NEFOPAM HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 127550461 | 12755046 | 10 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127550461 | 12755046 | 1 | Diffuse large B-cell lymphoma |
| 127550461 | 12755046 | 2 | Diffuse large B-cell lymphoma |
| 127550461 | 12755046 | 3 | Diffuse large B-cell lymphoma |
| 127550461 | 12755046 | 4 | Diffuse large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127550461 | 12755046 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127550461 | 12755046 | Asthenia | |
| 127550461 | 12755046 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127550461 | 12755046 | 1 | 20160818 | 20160818 | 0 | |
| 127550461 | 12755046 | 2 | 20160818 | 20160818 | 0 | |
| 127550461 | 12755046 | 3 | 20160817 | 20160819 | 0 | |
| 127550461 | 12755046 | 4 | 20160817 | 20160817 | 0 |